Procedure for Reviewing Pharmaceutical Inspections in the Eurasian Economic Union (Review)
Introduction. The article discusses significant changes in the procedure for pharmaceutical inspection of drug manufacturers for compliance with the requirements of the rules of good manufacturing practice (GMP) of the Eurasian Economic Union (EAEU), related to restrictions due to the COVID-19 pande...
Saved in:
| Main Authors: | A. P. Meshkovskiy, V. V. Beregovykh, V. N. Shestakov, N. V. Pyatigorskaya, Zh. I. Aladysheva, N. S. Nikolenko, A. M. Pyatigorskiy, E. I. Nesterkina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2021-08-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Responsibilities of the Marketing Authorisation Holders in Respect of GMP Compliance (Review)
by: A. P. Meshkovskiy, et al.
Published: (2020-11-01) -
Evaluation of New Risk-based Regulatory Approach to Classification of GMP Deficiencies (Review)
by: V. N. Shestakov, et al.
Published: (2020-08-01) -
RISK ANALYSIS OF THE DEFICIENCIES FOUND BY THE GMP INSPECTIONS
by: Yu. V. Podpruznikov, et al.
Published: (2019-01-01) -
SOME ASPECTS OF CONDUCTING GMP INSPECTIONS IN RUSSIA
by: G. N. Gildeeva, et al.
Published: (2018-03-01) -
OVERVIEW OF GMP INSPECTIONS RESULTS OF FOREIGN MANUFACTURING SITES IN 2017
by: V. A. Orlov
Published: (2019-01-01)